Entamoeba histolytica and Entamoeba dispar: Differentiation by Enzyme-Linked Immunosorbet Assay (ELISA) and its clinical correlation in pediatric patients

Parasitologia Latinoamericana

Volumn 61, Issue 1-2, 2006, Pages 37-42

  Bernal Redondo, Rosamaría ^a   Martínez Méndez, Laura G ^a   Baer, George ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b Laboratorios Baer   (Mexico)

Author keywords

Clinical laboratory techniques; Entamoeba histolytica E. dispar; Entamoebosis intestinal

Indexed keywords

ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA;

EID: 33746136070     PISSN: 07177704     EISSN: 07177712     Source Type: Journal    
DOI: 10.4067/S0717-77122006000100006     Document Type: Article

References (27)

1. ESCANDON R C, GÓMEZ H J L, CABRAL S J, et al. Detection of anti-Entamoeba histolytica IgA salivary antibodies: evaluation of its diagnostic capability in a rural setting. Arch Med Res 1997; 28 Suppl: S306-S308.
2. DAVILA C, VASQUEZ C, TRUJILLO B, et al. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg 2002; 66: 251-4.
3. ROMERO R, ROBERT L, MUÑOZ R, et al. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 1997; 91: 701-3.
4. RAMOS F, VALDEZ E, MORAN P, et al. Prevalence of Entamoeba histolytica and Entamoeba dispar in highly endemic rural population. Arch Med Res 2000; 31: S34-S35.
5. DÍAZ E, MONDRAGON J, RAMÍREZ E, et al. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003; 68: 384-5.
6. Epidemiología. Sistema Nacional de Vigilancia Epidemiologica 2004; 21: 11. E-mail. chector@epi. org.mx
7. WALSH J A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Inf Dis 1986; 8: 228-38.
8. ESPINOSA M, MARTÍNEZ-PALOMO A. Patho-genesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rew 2000; 13: 318-31.
9. HOOSHYAR H, REZAIAN M, KAZEMI B, et al. The distribution of Entamoeba histolytica and Entamoeba dispar in northern, central and southern Iran. Parasitol Res 2004; 94: 96-100.
10. HUSTON C D, PETRI W A. Amebiasis: clinical implications of the recognition of Entamoeba dispar. Infect Dis Rep 1999; 1: 441-7.
11. BRUMPT E. Estude sommaire de 1' Entamoeba dispar m sp Amiba a kyste quadrinuclear, parasite de l'homme Bull Acad Med (Paris) 1925; 94: 943-52.
12. PETRI W A, JACKSON T F, GATHIRAM V, et al. Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin. Infect Immun 1990; 58: 1802-6.
13. GONZÁLEZ R A, HAQUE R, AGUIRRE A, et al. Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica. J Clin Pathol 1994; 47: 236-9.
14. DIAMOND L S, CLARK C G. A redescription of Entamoeba histolytica Shaudinn 1903 (amended Walker 1911) separating it from Entamoeba dispar (Brumpt 1925). J Eukaryot Microbiol 1993; 40: 340-4.
15. TANNICH E, HORSMANN R D, KNOBLOCH J, et al. Genonic differences between pathogenic and nonpathogenic Entamoeba histolytica Proc Natl Acad Sci USA 1989; 86: 518-22.
16. WORLD HEALTH ORGANIZATION (WHO) News and activities. Washington 1997.
17. NATIONAL COMMITTEE FOR CLINICAL LABORATORY (NCCLS). Procedures for the recovery and identification of parasites from the intestinal tract. Approved guideline. Pennsylvania 1997.
18. nd ed. Washington, D.C. 1993. p. 6-17.
19. GATTI S, SWIERCZYNSKI G, ROBISON F, et al. Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in remote rural area of Ecuador. Am J Trop Med Hyg 2002; 67: 123-7.
20. RIVERA W L, TACHIBANA H, KANBARA H. Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the northern Philippines as detected by the polymerase chain reaction. Am J Trop Med Hyg 1998; 59: 916-21.
21. HAQUE R, FARUQUE A S G, HAHN P, et al. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. J Infec Dis 1997; 175: 734-5.
22. NESBITT R A, MOSHA F W, KATKI H A, et al. Amebiasis and comparison of microcopy to ELISA technique in detection of Entamoeba histolytica and Entamoeba dispar in fecal samples. J Natl Med Assoc 2004; 96: 671-7.
23. BLESSMANN J, BUSS H, TON U N P, et al. Real-time PCR for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in fecal samples. J Clin Microbiol 2002; 40: 4413-7.
24. HAQUE R, ALI K M, AKTHER S, et al. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnostic of Entamoeba histolytica infection. J Clin Microbiol 1998; 36: 449-52.
25. EL-HAMSHARY E M, E-SHEWRY K A, HEGAZY M M, et al. Diagnostic potentials of coproantigen detection for diagnostic of Entamoeba histolytica infection. J Clin Microbiol 1998; 36: 449-52.
26. DELALIOGLU N, ASLAN G, SPZEN M, et al. Detection of Entamoeba histolytica/Entamoeba dispar in stool specimens by using enzyme-linked immunosorbent assay. Mem Inst Oswaldo Cruz Rio de Janeiro 2004; 99: 769-72.
27. HAQUE R, MOLLAH N, ALI I, et al. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol 2000; 38: 3235-9.